Details for Patent: 11,723,905
✉ Email this page to a colleague
Which drugs does patent 11,723,905 protect, and when does it expire?
Patent 11,723,905 protects REZLIDHIA and is included in one NDA.
This patent has seventeen patent family members in fourteen countries.
Drugs Protected by US Patent 11,723,905
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rigel Pharms Inc | REZLIDHIA | olutasidenib | CAPSULE;ORAL | 215814-001 | Dec 1, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,723,905
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Denmark | 3720442 | ⤷ Sign Up | |||
European Patent Office | 3720442 | ⤷ Sign Up | |||
European Patent Office | 4215197 | ⤷ Sign Up | |||
Spain | 2941079 | ⤷ Sign Up | |||
Finland | 3720442 | ⤷ Sign Up | |||
Croatia | P20230168 | ⤷ Sign Up | |||
Hungary | E061331 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |